C52H58N16O3 — CID 159430731
N-[8-[5-cyano-6-[(1-methylpyrazol-4-yl)amino]pyrazin-2-yl]-8-azabicyclo[3.2.1]octan-2-yl]-4-cyclopropylbenzamide;5-[2-[(4-cyclopropylbenzoyl)amino]-8-azabicyclo[3.2.1]octan-8-yl]-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carboxamide (PubChem CID 159430731) has the molecular formula C52H58N16O3 and a molecular weight of 955.14 g/mol. Its IUPAC name is N-[8-[5-cyano-6-[(1-methylpyrazol-4-yl)amino]pyrazin-2-yl]-8-azabicyclo[3.2.1]octan-2-yl]-4-cyclopropylbenzamide;5-[2-[(4-cyclopropylbenzoyl)amino]-8-azabicyclo[3.2.1]octan-8-yl]-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carboxamide.
| Compound Name | N-[8-[5-cyano-6-[(1-methylpyrazol-4-yl)amino]pyrazin-2-yl]-8-azabicyclo[3.2.1]octan-2-yl]-4-cyclopropylbenzamide;5-[2-[(4-cyclopropylbenzoyl)amino]-8-azabicyclo[3.2.1]octan-8-yl]-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carboxamide |
|---|---|
| PubChem CID | 159430731 |
| Molecular Formula | C52H58N16O3 |
| Molecular Weight | 955.14 g/mol |
| Exact Mass | 954.49 |
| IUPAC Name | N-[8-[5-cyano-6-[(1-methylpyrazol-4-yl)amino]pyrazin-2-yl]-8-azabicyclo[3.2.1]octan-2-yl]-4-cyclopropylbenzamide;5-[2-[(4-cyclopropylbenzoyl)amino]-8-azabicyclo[3.2.1]octan-8-yl]-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carboxamide |
| SMILES | Cn1cc(Nc2nc(N3C4CCC(NC(=O)c5ccc(C6CC6)cc5)C3CC4)cnc2C#N)cn1.Cn1cc(Nc2nc(N3C4CCC(NC(=O)c5ccc(C6CC6)cc5)C3CC4)cnc2C(N)=O)cn1 |
| InChI | InChI=1S/C26H30N8O2.C26H28N8O/c1-33-14-18(12-29-33)30-25-23(24(27)35)28-13-22(32-25)34-19-8-10-20(21(34)11-9-19)31-26(36)17-6-4-16(5-7-17)15-2-3-15;1-33-15-19(13-29-33)30-25-22(12-27)28-14-24(32-25)34-20-8-10-21(23(34)11-9-20)31-26(35)18-6-4-17(5-7-18)16-2-3-16/h4-7,12-15,19-21H,2-3,8-11H2,1H3,(H2,27,35)(H,30,32)(H,31,36);4-7,13-16,20-21,23H,2-3,8-11H2,1H3,(H,30,32)(H,31,35) |
| InChIKey | LQYJPVNTTRGKNS-UHFFFAOYSA-N |
| XLogP | 6.49 |
| TPSA | 242.82 Ų |
| H-Bond Donors | 5 |
| H-Bond Acceptors | 16 |
| Rotatable Bonds | 13 |
| Heavy Atoms | 71 |
| Complexity | — |
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 955.14 |
| LogP ≤ 5 | 6.49 |
| H-Bond Donors ≤ 5 | 5 |
| H-Bond Acceptors ≤ 10 | 16 |